AAAAAA

   
Results: 1-25 | 26-32 |
Results: 26-32/32
ORAL DICLOFENAC COMBINED WITH INTRA-PORTAL PIRARUBICIN - INCREASED EFFICACY ON LIVER VX2 TUMOR AND HEPATOTOXICITY IN RABBITS
Authors: DONATINI B BOGNEL C MUNCK JN RAMIREZ L ARDOUIN P ROUGIER P
Citation: B. Donatini et al., ORAL DICLOFENAC COMBINED WITH INTRA-PORTAL PIRARUBICIN - INCREASED EFFICACY ON LIVER VX2 TUMOR AND HEPATOTOXICITY IN RABBITS, Journal of cancer research and clinical oncology, 120(9), 1994, pp. 529-532
VERAPAMIL-REVERSING CONCENTRATIONS INDUCE BLOOD-FLOW CHANGES THAT COULD COUNTERACT IN-VIVO THE MDR-1-MODULATING EFFECTS
Authors: RAMIREZ LH MUNCK JN ZHAO ZX BOGNEL C RICARD M ARDOUIN P ROUGIER P GOUYETTE A
Citation: Lh. Ramirez et al., VERAPAMIL-REVERSING CONCENTRATIONS INDUCE BLOOD-FLOW CHANGES THAT COULD COUNTERACT IN-VIVO THE MDR-1-MODULATING EFFECTS, Cancer, 74(3), 1994, pp. 810-816
AUTOLOGOUS TRANSPLANTATION OF CD34-MYELOMA (MM) PATIENTS (PTS) FOLLOWING A MYELOABLATIVE INTENSIVE THERAPY( SELECTED PERIPHERAL HEMATOPOIETIC PROGENITORS (PHP) LEADS TO DURABLE ENGRAFTMENT IN MULTIPLE)
Authors: BOURHIS JH BEAUJEAN F BAYLE C BRAULT P IBRAHIM A BENNACEUR AL LAPIERRE V DAVEZE O BENHAMOU E PANELATTI G DECAUDIN D MUNCK JN DIGHIERO G TCHERNIA G HAYAT M PICO JL
Citation: Jh. Bourhis et al., AUTOLOGOUS TRANSPLANTATION OF CD34-MYELOMA (MM) PATIENTS (PTS) FOLLOWING A MYELOABLATIVE INTENSIVE THERAPY( SELECTED PERIPHERAL HEMATOPOIETIC PROGENITORS (PHP) LEADS TO DURABLE ENGRAFTMENT IN MULTIPLE), Blood, 84(10), 1994, pp. 10000209-10000209
MANTLE CELL LYMPHOMA - A RETROSPECTIVE STUDY OF 47 CASES BETWEEN 1978AND 1993 IN THE INSTITUT-GUSTAVE-ROUSSY
Authors: DECAUDIN D MUNCK JN BAYLE C BOURHIS JH BOSQ J KOSCIELNY S BENNACEUR AL MORDACQ M IBRAHIM A DHERMAIN F PICO JL HAYAT M
Citation: D. Decaudin et al., MANTLE CELL LYMPHOMA - A RETROSPECTIVE STUDY OF 47 CASES BETWEEN 1978AND 1993 IN THE INSTITUT-GUSTAVE-ROUSSY, Blood, 84(10), 1994, pp. 10000450-10000450
WHICH PATIENTS WITH LYMPHOMA SHOULD HAVE MAGNETIC-RESONANCE-IMAGING (MRI) OF BONE-MARROW
Authors: TARDIVON A MUNCK JN KOSCIELNY S DECAUDIN D DHERMAIN F BOSQ J BOURHIS JH IBRAHIM A PICO JL HAYAT M
Citation: A. Tardivon et al., WHICH PATIENTS WITH LYMPHOMA SHOULD HAVE MAGNETIC-RESONANCE-IMAGING (MRI) OF BONE-MARROW, Blood, 84(10), 1994, pp. 10000649-10000649
PHARMACOLOGY AND ANTITUMOR EFFECTS OF INTRAPORTAL PIRARUBICIN ON EXPERIMENTAL LIVER METASTASES
Authors: RAMIREZ LH MUNCK JN BOGNEL C ZHAO Z ARDOUIN P POUPON MF GOUYETTE A ROUGIER P
Citation: Lh. Ramirez et al., PHARMACOLOGY AND ANTITUMOR EFFECTS OF INTRAPORTAL PIRARUBICIN ON EXPERIMENTAL LIVER METASTASES, British Journal of Cancer, 68(2), 1993, pp. 277-281
NEOADJUVANT CHEMOTHERAPY IN MULTIPLE SYNCHRONOUS HEAD AND NECK AND ESOPHAGUS SQUAMOUS-CELL CARCINOMAS
Authors: GUILLOT T SPIELMANN M KAC J LUBOINSKI B TELLEZBERNAL E MUNCK JN BACHOUCHI M ARMAND JP CVITKOVIC E
Citation: T. Guillot et al., NEOADJUVANT CHEMOTHERAPY IN MULTIPLE SYNCHRONOUS HEAD AND NECK AND ESOPHAGUS SQUAMOUS-CELL CARCINOMAS, The Laryngoscope, 102(3), 1992, pp. 311-319
Risultati: 1-25 | 26-32 |